Nordstrom, Inc. JWN is scheduled to release fourth-quarter fiscal 2019 numbers on Mar 3, after the closing bell. In the last reported quarter, the fashion specialty retailer recorded a positive earnings surprise of 24.6%. In the trailing four quarters, the company’s bottom lin
Investors are always looking for stocks that are poised to beat at earnings season and Precigen, Inc. PGEN may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Investors are always looking for stocks that are poised to beat at earnings season and Baxter International Inc. BAX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Baxter is seeing fav
Investors are always looking for stocks that are poised to beat at earnings season and The Toronto-Dominion Bank TD may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Toronto-Dominion Bank
Investors are always looking for stocks that are poised to beat at earnings season and Radius Health, Inc. RDUS may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Horizon Therapeutics (HZNP) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.
Frontdoor (FTDR) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.
Investors are always looking for stocks that are poised to beat at earnings season and CenterPoint Energy, Inc. CNP may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because CenterPoint Energy is
Cambridge, MA-based Moderna, Inc. MRNA is a clinical-stage pharmaceutical company primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company does not have any marketed products in its portfolio. It derives revenues from its collaboration pa
Investors are always looking for stocks that are poised to beat at earnings season and Baidu, Inc. BIDU may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Baidu is seeing favorable earning
Investors are always looking for stocks that are poised to beat at earnings season and Sage Therapeutics, Inc. SAGE may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Ionis Pharmaceuticals (IONS) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $2.42 per share a year ago. These figures are adjusted for non-recurring items.
AMC Networks (AMCX) came out with quarterly earnings of $1.69 per share, missing the Zacks Consensus Estimate of $1.73 per share. This compares to earnings of $1.92 per share a year ago. These figures are adjusted for non-recurring items.
Wendy's (WEN) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.
FTI Consulting, Inc. FCN delivered mixed fourth-quarter 2019 results, with earnings missing the Zacks Consensus Estimate but revenues beating the same.
On Feb 25, we issued an updated research report on Carpenter Technology Corporation CRS. The company’s efforts to strengthen customer relationships, execution of its commercial strategy, acquisitions and investments in additive manufacturing will fuel growth. Also, solid deman
Unless you've been hiding under a rock, you've been hearing a lot about the coronavirus, which is dominating investors' minds this week and driving down equity indices around the world.
Dycom Industries (DY) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
Drinks giant Diageo warned the coronavirus outbreak could hit profits by up to £200 million in 2020, as companies began to measure the impact of the epidemic.
Barrons
Checked
16 minutes 51 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks